Clarivate Plc (CLVT)
Market Cap | 3.89B |
Revenue (ttm) | 2.58B |
Net Income (ttm) | -1.34B |
Shares Out | 710.40M |
EPS (ttm) | -1.96 |
PE Ratio | n/a |
Forward PE | 7.52 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,474,313 |
Open | 5.36 |
Previous Close | 5.36 |
Day's Range | 5.32 - 5.52 |
52-Week Range | 4.25 - 9.61 |
Beta | 1.15 |
Analysts | Hold |
Price Target | 7.10 (+29.8%) |
Earnings Date | Feb 19, 2025 |
About CLVT
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academi... [Read more]
Financial Performance
In 2023, Clarivate's revenue was $2.63 billion, a decrease of -1.17% compared to the previous year's $2.66 billion. Losses were -$986.60 million, -75.55% less than in 2022.
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for CLVT stock is "Hold." The 12-month stock price forecast is $7.1, which is an increase of 29.80% from the latest price.
News
Clarivate to Report Fourth Quarter and Full Year 2024 Results on February 19, 2025
LONDON , Jan. 22, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the fourth quarter...
BioWorld by Clarivate Releases Comprehensive 2024 Year in Review
Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON , Jan. 16, 2025 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global pr...
Post-marketing Pharmacovigilance and Medical Information Market Research 2024: Rising Adverse Drug Reactions (ADRs) and Expanding Use of Biologics and Specialty Drugs Fueling Growth - Forecast to 2034
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Post-marketing Pharmacovigilance and Medical Information Market by Type by Service, by End-User, and By Region" report has been added to ResearchAndMarke...
Clarivate Launches DRG Fusion - A New Life Sciences Analytics Product Powered by Real-World Data
New modular analytics solution empowers commercial teams to optimize strategies and improve patient outcomes LONDON , Jan. 14, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider...
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON , Jan. 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provid...
Clarivate Announces New $500 Million Share Repurchase Authorization
LONDON , Dec. 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today announced that its Board of Directors (...
Clarivate Launches AI-Powered Patent Search Solution in Derwent
Faster and more relevant results to empower critical IP decision-making LONDON , Dec. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, tod...
Clarivate and the Chinese Academy of Sciences Release Annual Collaborative Report to Identify 125 Research Fronts
Revealing highly active specialties in sciences and social sciences LONDON , Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, and the...
Daikin Selects IPfolio from Clarivate
Enhancing operational efficiency for leading air conditioner manufacturer LONDON , Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, a...
BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series
New seven-part series explores disparities in care, funding and innovation impacting half the world's population LONDON , Nov. 21, 2024 /PRNewswire/ -- BioWorld ™ published by Clarivate Plc (NYSE:C...
Clarivate Reveals Highly Cited Researchers 2024 List
Prioritizing research integrity with enhanced filters to address publication and citation manipulation LONDON , Nov. 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of tr...
New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence
New report analyses Mainland China's transformation into a global biopharma powerhouse, with key insights for international stakeholders LONDON , Nov. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT...
Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners
Recognizing Roper St. Francis Healthcare, Bon Secours Mercy Health, and Bronson Methodist Hospital for excellence in Physician and Hospital Groups LONDON , Nov. 13, 2024 /PRNewswire/ -- Clarivate Plc ...
Clarivate Publishes 2023 Sustainability Report
LONDON , Nov. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has today published its fourth annual sustainability report, showcasing its ...
Clarivate: Downgrade To Hold As Growth May Take A Long Time To Recover
I downgrade Clarivate PLC from buy to hold due to lack of confidence in near-term organic growth recovery and potential further stock price decline. CLVT's 3Q24 earnings report showed a 3.9% revenue d...
Clarivate Launches New Sustainability Research Solution
ProQuest One Sustainability offers a transdisciplinary research experience and features AI-powered ProQuest Research Assistant LONDON , Nov. 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leadin...
Clarivate Plc (CLVT) Q3 2024 Earnings Call Transcript
Clarivate Plc (NYSE:CLVT) Q3 2024 Earnings Conference Call November 6, 2024 9:00 AM ET Company Participants Mark Donohue - Vice President of Investor Relations Matti Shem Tov - Chief Executive Office...
Clarivate Reports Third Quarter 2024 Results
LONDON , Nov. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the third quarter ...
Thompson Street Portfolio Company Silverchair Announces Agreement to Acquire Scholarone
ST. LOUIS--(BUSINESS WIRE)--Silverchair, a portfolio company of Thompson Street Capital Partners (TSCP), announced today that is has entered into a definitive agreement with Clarivate Plc (NYSE:CLVT) ...
Clarivate to Report Third Quarter 2024 Results on November 6, 2024
LONDON , Oct. 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the third quarter ...
Clarivate Repeats Success in Nobel Prize Predictions with Eight New Winners Identified by Citation Laureates Program
83 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002 LONDON , Oct. 15, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provid...
Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda
Top industry leaders to explore AI, data, strategic partnerships, and innovation opportunities in Latin America at premier Life Sciences event LONDON , Oct. 4, 2024 /PRNewswire/ -- Clarivate Plc (NYSE...
Clarivate Unveils Comprehensive Framework to Evaluate the Societal Impact of Research
LONDON , Sept. 25, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the development of a comprehensive framework for evaluating...
New Clarivate Report Reveals Challenges and Trends Shaping IP Operations
Sharing benchmarks and strategies to elevate IP practices LONDON , Sept. 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released a...
Clarivate and Relatable Healthcare Forge Strategic Partnership to Transform Medtech Sales Contracting Process
Clarivate Medtech Intelligence and Relatable software enhance product data management and competitive conversion efficiency for medtech sales, contracting and pricing teams LONDON , Sept. 23, 2024 /PR...